Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Lithium is a cornerstone treatment for Bipolar Mood Disorder, with its use supported by extensive scientific evidence. Since the late 1940s, when John Cade discovered its mood-stabilizing effects, lithium has undergone rigorous clinical testing. Numerous randomized controlled trials and meta-analyses have established lithium as highly effective in reducing the frequency and severity of both manic and depressive episodes in bipolar disorder. It is particularly noted for its ability to prevent relapse and for its anti-suicidal properties, which have been demonstrated in large, longitudinal studies.

Guidelines from leading psychiatric organizations, such as the American Psychiatric Association and the UK’s National Institute for Health and Care Excellence (NICE), recommend lithium as a first-line treatment for bipolar disorder. The mechanism of action is not fully understood, but lithium is believed to modulate neurotransmitter release, inhibit inositol monophosphatase, and affect intracellular signaling pathways involved in mood regulation.

While lithium treatment requires regular monitoring due to its narrow therapeutic index and potential side effects (notably renal and thyroid dysfunction), its efficacy in long-term mood stabilization is unmatched by most other agents. Overall, lithium’s use in bipolar disorder is not only traditional but is also robustly validated by decades of scientific research.

More about Lithium
More about Bipolar Mood Disorder

Other ingredients used for Bipolar Mood Disorder

Other health conditions supported by Lithium

Products containing Lithium